Icon (ICLR) Net Cash Flow (2009 - 2026)
Icon's (ICLR) quarterly Net Cash Flow came in at $164.8 million in Q2 2026, up 211.46% year-over-year from $52.9 million in Q2 2025, and up 35.98% quarter-over-quarter from $121.2 million in Q1 2026.
Analysis
Icon (ICLR) Net Cash Flow (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Net Cash Flow for 18 consecutive years, with $164.8 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Cash Flow rose 211.46% year-over-year to $164.8 million in Q2 2026; TTM through Jun 2026 was $890.8 million, a 334.48% increase from a year earlier, with the FY2025 full-year figure at $435.0 million, down 14.94% from the prior year.
- Net Cash Flow was $164.8 million for Q2 2026 at Icon, up from $121.2 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $530.0 million in Q4 2025 and troughed at -$311.4 million in Q4 2022.
- A 5-year average of $48.7 million and a median of $54.0 million in 2022 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow plunged 280.41% in 2022 and soared 1285.91% in 2024, its largest moves.
- Over 5 years, Net Cash Flow stood at -$311.4 million in 2022, then soared by 119.93% to $62.1 million in 2023, then jumped by 212.82% to $194.2 million in 2024, then surged by 172.91% to $530.0 million in 2025, then slumped by 68.9% to $164.8 million in 2026.
- The last three Net Cash Flow figures came in at $164.8 million (Q2 2026), $121.2 million (Q1 2026), and $530.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -37.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -150.21 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 164.82 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 43.16 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 21.90 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -16.70 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -514,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -2.71 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -3.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 164.82 Mn |
| Mar 31, 2026 | 121.21 Mn |
| Dec 31, 2025 | 530.01 Mn |
| Sep 30, 2025 | 74.73 Mn |
| Jun 30, 2025 | -147.87 Mn |
| Mar 31, 2025 | -21.87 Mn |
| Dec 31, 2024 | 194.21 Mn |
| Sep 30, 2024 | 180.55 Mn |
| Jun 30, 2024 | 112.64 Mn |
| Mar 31, 2024 | 24.01 Mn |
| Dec 31, 2023 | 62.08 Mn |
| Sep 30, 2023 | 47.35 Mn |
| Jun 30, 2023 | -9.50 Mn |
| Mar 31, 2023 | -9.61 Mn |
| Dec 31, 2022 | -311.45 Mn |
| Sep 30, 2022 | -10.74 Mn |
| Jun 30, 2022 | 60.60 Mn |
| Mar 31, 2022 | -185.13 Mn |
| Dec 31, 2021 | -254.66 Mn |
| Sep 30, 2021 | -40.35 Mn |